The EU Commission conditionally clears the acquisition of a Belgian pharmaceuticals company by a US competitor (Abbott / Solvay Pharmaceuticals)

"Merger: main developments between 1 January and 30 April 2010" On 11 February the Commission approved the proposed acquisition of Solvay Pharma (Belgium) by Abbott Laboratories (USA). The decision is conditional upon the divestment of the Cystic Fibrosis testing business of Solvay Pharma’s

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

PDF Version

Author

  • JG Associates (Brussels)

Quotation

John Gatti, The EU Commission conditionally clears the acquisition of a Belgian pharmaceuticals company by a US competitor (Abbott / Solvay Pharmaceuticals), 11 February 2010, e-Competitions February 2010, Art. N° 37500

Visites 343

All issues

  • Latest News issue 
  • All News issues
  • Latest Special issue 
  • All Special issues